🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsTirzepatide (Mounjaro / Zepbound)The sulfur burps are KILLING me someone help — 6 month update Page 2

The sulfur burps are KILLING me someone help — 6 month update

NeuroNate Mon, Aug 25, 2025 at 3:09 AM 14 replies 1,315 viewsPage 2 of 3
SarahChen_PharmD
VIP Member
4,567
22,341
Dec 2023
San Diego, CA
Aug 25, 2025 at 12:18 PM#6
COA_Karl said:
The line between titrate-through and stop is not severity, it is trajectory and what else is present.

I dislike how confidently this board tells people to push through. Incidence figures around 20 to 25% at the higher doses are class-typical, but the trials also had a discontinuation column, and "manageable with protocols" is not the same as manageable for everyone.

15 18Dr.ObesityLA, NurseKim_ATL, paul_denver and 12 others
Reply Quote Save Share Report
DataDave
Senior Member
1,678
8,901
Apr 2024
Washington
Online
Aug 25, 2025 at 3:55 PM#7

The figures, for anyone assembling their own picture. Keep the original post as written when you update it, and add the correction underneath. An edited-away mistake is invisible to the next person who makes it.

Last edited: Aug 25, 2025 at 4:55 PM
16 19mike_nyc, VendorMark, COA_Karl and 13 others
Reply Quote Save Share Report
Dr.MetabolicMD
VIP Member
2,345
16,789
Jan 2024
Rochester, MN
Aug 25, 2025 at 7:32 PM#8
SarahChen_PharmD said:
I dislike how confidently this board tells people to push through.

Adding the part of the answer the thread has not reached. If two explanations both fit, the useful question is which one predicts something the other does not. That is answerable; arguing about which sounds more plausible is not.

Last edited: Aug 25, 2025 at 9:32 PM
17 20HealthEcon_DC, PedsEndoPhilly, SleepDoc_PDX and 14 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
zoe_NC
Member
278
1,234
Nov 2024
Charlotte, NC
Aug 25, 2025 at 11:09 PM#9

A narrower follow-up, since the general answer is now clear:

What distinguishes the nausea you can titrate through from the nausea that means stop?

Last edited: Aug 26, 2025 at 12:09 AM
18 21NicoleRaleigh, james_edin, FranDenver and 15 others
Reply Quote Save Share Report
NeuroNate
Senior Member
2,890
16,789
Dec 2023
Chicago, IL
Aug 26, 2025 at 4:30 PM#10

Closing the loop on my own question.

Update. It was not the dose, it was that I had stopped drinking anything because drinking made me feel full. Fixing that fixed most of it.

Last edited: Aug 26, 2025 at 10:30 PM
4 4Dr.NephBHM_UK, kim_atl_prep, sarah_TO and 1 other
Reply Quote Save Share Report

Similar Threads

SURMOUNT-5: Tirzepatide vs semaglutide head-to-head — full results11 replies
SURPASS 1-5 program: tirzepatide T2DM efficacy data compilation6 replies
Tirzepatide dual agonism: GIP + GLP-1 synergistic mechanism18 replies
5mg → 10mg → 15mg titration — clinical guidance and real-world data8 replies
Zepbound insurance coverage — payer-by-payer breakdown 20268 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register